drugset / Trial / NCT01072591
Study to Assess MEDI -578 in Patients With Osteoarthritis (OA) of the Knee
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to evaluate the safety and tolerability of a single intravenous dose of MEDI-578, a monoclonal antibody, in patients with osteoarthritis of the knee. It will also be evaluated how MEDI-578 is absorbed and distributed through the body.
Timeline
- Start
- 2010-02
- Primary completion
- 2010-09
- Completion
- 2010-09
Outcome
Outcome not reported
Stopped: “Amended clinical development plan.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MEDI-578 | Monoclonal antibody | — | Intravenous |